nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—Acute pulmonary oedema—Docetaxel—melanoma	0.088	0.135	CcSEcCtD
Nebivolol—Oedema peripheral—Vemurafenib—melanoma	0.0121	0.0185	CcSEcCtD
Nebivolol—Cardiac disorder—Vemurafenib—melanoma	0.0114	0.0175	CcSEcCtD
Nebivolol—Malnutrition—Vemurafenib—melanoma	0.0107	0.0164	CcSEcCtD
Nebivolol—Bronchospasm—Bleomycin—melanoma	0.00912	0.014	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00902	0.0138	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00901	0.0138	CcSEcCtD
Nebivolol—Nervous system disorder—Vemurafenib—melanoma	0.00854	0.0131	CcSEcCtD
Nebivolol—Skin disorder—Vemurafenib—melanoma	0.00845	0.013	CcSEcCtD
Nebivolol—Acute coronary syndrome—Bleomycin—melanoma	0.00815	0.0125	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00815	0.0125	CcSEcCtD
Nebivolol—Myocardial infarction—Bleomycin—melanoma	0.0081	0.0124	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Vemurafenib—melanoma	0.00751	0.0115	CcSEcCtD
Nebivolol—Fatigue—Vemurafenib—melanoma	0.0075	0.0115	CcSEcCtD
Nebivolol—Erectile dysfunction—Temozolomide—melanoma	0.0072	0.0111	CcSEcCtD
Nebivolol—Hypersensitivity—Vemurafenib—melanoma	0.00641	0.00984	CcSEcCtD
Nebivolol—Oedema peripheral—Carmustine—melanoma	0.00638	0.0098	CcSEcCtD
Nebivolol—Asthenia—Vemurafenib—melanoma	0.00624	0.00959	CcSEcCtD
Nebivolol—Oedema peripheral—Temozolomide—melanoma	0.00617	0.00947	CcSEcCtD
Nebivolol—Pruritus—Vemurafenib—melanoma	0.00616	0.00945	CcSEcCtD
Nebivolol—Diarrhoea—Vemurafenib—melanoma	0.00596	0.00914	CcSEcCtD
Nebivolol—Cardiac disorder—Temozolomide—melanoma	0.00581	0.00892	CcSEcCtD
Nebivolol—Dizziness—Vemurafenib—melanoma	0.00576	0.00884	CcSEcCtD
Nebivolol—Mental disorder—Carmustine—melanoma	0.00568	0.00871	CcSEcCtD
Nebivolol—Malnutrition—Carmustine—melanoma	0.00564	0.00866	CcSEcCtD
Nebivolol—Vomiting—Vemurafenib—melanoma	0.00553	0.0085	CcSEcCtD
Nebivolol—Chest pain—Bleomycin—melanoma	0.0055	0.00844	CcSEcCtD
Nebivolol—Rash—Vemurafenib—melanoma	0.00549	0.00842	CcSEcCtD
Nebivolol—Mental disorder—Temozolomide—melanoma	0.00549	0.00842	CcSEcCtD
Nebivolol—Dermatitis—Vemurafenib—melanoma	0.00548	0.00842	CcSEcCtD
Nebivolol—Headache—Vemurafenib—melanoma	0.00545	0.00837	CcSEcCtD
Nebivolol—Malnutrition—Temozolomide—melanoma	0.00545	0.00837	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00542	0.00832	CcSEcCtD
Nebivolol—Nausea—Vemurafenib—melanoma	0.00517	0.00794	CcSEcCtD
Nebivolol—Thrombocytopenia—Bleomycin—melanoma	0.00516	0.00793	CcSEcCtD
Nebivolol—Bronchospasm—Docetaxel—melanoma	0.00512	0.00786	CcSEcCtD
Nebivolol—Angioedema—Temozolomide—melanoma	0.00498	0.00765	CcSEcCtD
Nebivolol—Vertigo—Temozolomide—melanoma	0.0049	0.00752	CcSEcCtD
Nebivolol—Thrombocytopenia—Dactinomycin—melanoma	0.00482	0.00739	CcSEcCtD
Nebivolol—Chest pain—Carmustine—melanoma	0.0048	0.00737	CcSEcCtD
Nebivolol—Paraesthesia—Bleomycin—melanoma	0.00474	0.00727	CcSEcCtD
Nebivolol—Dyspnoea—Bleomycin—melanoma	0.0047	0.00722	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00461	0.00707	CcSEcCtD
Nebivolol—Acute coronary syndrome—Docetaxel—melanoma	0.00457	0.00702	CcSEcCtD
Nebivolol—Myocardial infarction—Docetaxel—melanoma	0.00455	0.00698	CcSEcCtD
Nebivolol—Thrombocytopenia—Carmustine—melanoma	0.00451	0.00692	CcSEcCtD
Nebivolol—Nervous system disorder—Temozolomide—melanoma	0.00436	0.0067	CcSEcCtD
Nebivolol—Thrombocytopenia—Temozolomide—melanoma	0.00436	0.00669	CcSEcCtD
Nebivolol—Skin disorder—Temozolomide—melanoma	0.00432	0.00663	CcSEcCtD
Nebivolol—Fatigue—Dactinomycin—melanoma	0.00424	0.00651	CcSEcCtD
Nebivolol—Urticaria—Bleomycin—melanoma	0.00419	0.00643	CcSEcCtD
Nebivolol—Insomnia—Carmustine—melanoma	0.00416	0.00639	CcSEcCtD
Nebivolol—Paraesthesia—Carmustine—melanoma	0.00413	0.00635	CcSEcCtD
Nebivolol—Dyspnoea—Carmustine—melanoma	0.0041	0.0063	CcSEcCtD
Nebivolol—Oedema peripheral—Docetaxel—melanoma	0.0041	0.0063	CcSEcCtD
Nebivolol—Somnolence—Carmustine—melanoma	0.00409	0.00628	CcSEcCtD
Nebivolol—Insomnia—Temozolomide—melanoma	0.00402	0.00618	CcSEcCtD
Nebivolol—Gastrointestinal pain—Dactinomycin—melanoma	0.00402	0.00617	CcSEcCtD
Nebivolol—Paraesthesia—Temozolomide—melanoma	0.00399	0.00613	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Carmustine—melanoma	0.00397	0.0061	CcSEcCtD
Nebivolol—Dyspnoea—Temozolomide—melanoma	0.00397	0.00609	CcSEcCtD
Nebivolol—Somnolence—Temozolomide—melanoma	0.00395	0.00607	CcSEcCtD
Nebivolol—Abdominal pain—Dactinomycin—melanoma	0.00389	0.00597	CcSEcCtD
Nebivolol—Hypersensitivity—Bleomycin—melanoma	0.00389	0.00596	CcSEcCtD
Nebivolol—Cardiac disorder—Docetaxel—melanoma	0.00386	0.00593	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Temozolomide—melanoma	0.00384	0.0059	CcSEcCtD
Nebivolol—Fatigue—Temozolomide—melanoma	0.00384	0.00589	CcSEcCtD
Nebivolol—Asthenia—Bleomycin—melanoma	0.00378	0.00581	CcSEcCtD
Nebivolol—Gastrointestinal pain—Carmustine—melanoma	0.00376	0.00578	CcSEcCtD
Nebivolol—Pruritus—Bleomycin—melanoma	0.00373	0.00573	CcSEcCtD
Nebivolol—Mental disorder—Docetaxel—melanoma	0.00365	0.0056	CcSEcCtD
Nebivolol—Abdominal pain—Carmustine—melanoma	0.00364	0.00559	CcSEcCtD
Nebivolol—Gastrointestinal pain—Temozolomide—melanoma	0.00364	0.00558	CcSEcCtD
Nebivolol—Malnutrition—Docetaxel—melanoma	0.00362	0.00556	CcSEcCtD
Nebivolol—Hypersensitivity—Dactinomycin—melanoma	0.00362	0.00556	CcSEcCtD
Nebivolol—Urticaria—Temozolomide—melanoma	0.00353	0.00542	CcSEcCtD
Nebivolol—Asthenia—Dactinomycin—melanoma	0.00353	0.00542	CcSEcCtD
Nebivolol—Abdominal pain—Temozolomide—melanoma	0.00352	0.0054	CcSEcCtD
Nebivolol—Hypersensitivity—Carmustine—melanoma	0.00339	0.00521	CcSEcCtD
Nebivolol—Diarrhoea—Dactinomycin—melanoma	0.00336	0.00517	CcSEcCtD
Nebivolol—Vomiting—Bleomycin—melanoma	0.00335	0.00515	CcSEcCtD
Nebivolol—Rash—Bleomycin—melanoma	0.00332	0.0051	CcSEcCtD
Nebivolol—Dermatitis—Bleomycin—melanoma	0.00332	0.0051	CcSEcCtD
Nebivolol—Asthenia—Carmustine—melanoma	0.0033	0.00507	CcSEcCtD
Nebivolol—Hypersensitivity—Temozolomide—melanoma	0.00328	0.00503	CcSEcCtD
Nebivolol—Syncope—Docetaxel—melanoma	0.00325	0.00499	CcSEcCtD
Nebivolol—Asthenia—Temozolomide—melanoma	0.00319	0.0049	CcSEcCtD
Nebivolol—Loss of consciousness—Docetaxel—melanoma	0.00319	0.00489	CcSEcCtD
Nebivolol—Diarrhoea—Carmustine—melanoma	0.00315	0.00483	CcSEcCtD
Nebivolol—Pruritus—Temozolomide—melanoma	0.00315	0.00483	CcSEcCtD
Nebivolol—Nausea—Bleomycin—melanoma	0.00313	0.00481	CcSEcCtD
Nebivolol—Vomiting—Dactinomycin—melanoma	0.00313	0.0048	CcSEcCtD
Nebivolol—Rash—Dactinomycin—melanoma	0.0031	0.00476	CcSEcCtD
Nebivolol—Chest pain—Docetaxel—melanoma	0.00309	0.00474	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00306	0.0047	CcSEcCtD
Nebivolol—Dizziness—Carmustine—melanoma	0.00304	0.00467	CcSEcCtD
Nebivolol—Diarrhoea—Temozolomide—melanoma	0.00304	0.00467	CcSEcCtD
Nebivolol—Dizziness—Temozolomide—melanoma	0.00294	0.00452	CcSEcCtD
Nebivolol—Vomiting—Carmustine—melanoma	0.00293	0.00449	CcSEcCtD
Nebivolol—Nausea—Dactinomycin—melanoma	0.00292	0.00448	CcSEcCtD
Nebivolol—Shock—Docetaxel—melanoma	0.00291	0.00447	CcSEcCtD
Nebivolol—Rash—Carmustine—melanoma	0.0029	0.00446	CcSEcCtD
Nebivolol—Nervous system disorder—Docetaxel—melanoma	0.0029	0.00445	CcSEcCtD
Nebivolol—Dermatitis—Carmustine—melanoma	0.0029	0.00445	CcSEcCtD
Nebivolol—Thrombocytopenia—Docetaxel—melanoma	0.0029	0.00445	CcSEcCtD
Nebivolol—Headache—Carmustine—melanoma	0.00288	0.00443	CcSEcCtD
Nebivolol—Skin disorder—Docetaxel—melanoma	0.00287	0.00441	CcSEcCtD
Nebivolol—Vomiting—Temozolomide—melanoma	0.00283	0.00434	CcSEcCtD
Nebivolol—Rash—Temozolomide—melanoma	0.0028	0.00431	CcSEcCtD
Nebivolol—Dermatitis—Temozolomide—melanoma	0.0028	0.0043	CcSEcCtD
Nebivolol—Headache—Temozolomide—melanoma	0.00279	0.00428	CcSEcCtD
Nebivolol—Nausea—Carmustine—melanoma	0.00273	0.0042	CcSEcCtD
Nebivolol—Insomnia—Docetaxel—melanoma	0.00268	0.00411	CcSEcCtD
Nebivolol—Paraesthesia—Docetaxel—melanoma	0.00266	0.00408	CcSEcCtD
Nebivolol—Nausea—Temozolomide—melanoma	0.00264	0.00406	CcSEcCtD
Nebivolol—Dyspnoea—Docetaxel—melanoma	0.00264	0.00405	CcSEcCtD
Nebivolol—Somnolence—Docetaxel—melanoma	0.00263	0.00404	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Docetaxel—melanoma	0.00255	0.00392	CcSEcCtD
Nebivolol—Fatigue—Docetaxel—melanoma	0.00255	0.00392	CcSEcCtD
Nebivolol—Gastrointestinal pain—Docetaxel—melanoma	0.00242	0.00371	CcSEcCtD
Nebivolol—Abdominal pain—Docetaxel—melanoma	0.00234	0.00359	CcSEcCtD
Nebivolol—Hypersensitivity—Docetaxel—melanoma	0.00218	0.00335	CcSEcCtD
Nebivolol—Asthenia—Docetaxel—melanoma	0.00212	0.00326	CcSEcCtD
Nebivolol—Pruritus—Docetaxel—melanoma	0.00209	0.00321	CcSEcCtD
Nebivolol—Diarrhoea—Docetaxel—melanoma	0.00202	0.00311	CcSEcCtD
Nebivolol—Dizziness—Docetaxel—melanoma	0.00196	0.003	CcSEcCtD
Nebivolol—Vomiting—Docetaxel—melanoma	0.00188	0.00289	CcSEcCtD
Nebivolol—Rash—Docetaxel—melanoma	0.00187	0.00286	CcSEcCtD
Nebivolol—Dermatitis—Docetaxel—melanoma	0.00186	0.00286	CcSEcCtD
Nebivolol—Headache—Docetaxel—melanoma	0.00185	0.00284	CcSEcCtD
Nebivolol—Nausea—Docetaxel—melanoma	0.00176	0.0027	CcSEcCtD
Nebivolol—HTR1A—GPCR downstream signaling—PIK3CD—melanoma	0.000132	0.00038	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NGFR—melanoma	0.000131	0.000376	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ITGAV—melanoma	0.000131	0.000376	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AKT3—melanoma	0.000131	0.000376	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PLA2G6—melanoma	0.000131	0.000375	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SOCS1—melanoma	0.000127	0.000364	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—MAP2K1—melanoma	0.000126	0.000363	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—S100B—melanoma	0.000126	0.000363	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3CD—melanoma	0.000126	0.00036	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SOCS1—melanoma	0.000124	0.000356	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—MAP2K1—melanoma	0.000124	0.000355	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—S100B—melanoma	0.000124	0.000355	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3CD—melanoma	0.000123	0.000353	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SOCS1—melanoma	0.000121	0.000348	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—MAP2K1—melanoma	0.000121	0.000347	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—S100B—melanoma	0.000121	0.000347	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ERBB4—melanoma	0.000121	0.000347	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PIK3CB—melanoma	0.000121	0.000346	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3CD—melanoma	0.00012	0.000345	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CDKN2B—melanoma	0.00012	0.000344	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ERBB4—melanoma	0.000118	0.000339	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PIK3CB—melanoma	0.000118	0.000338	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—VCAN—melanoma	0.000117	0.000337	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CDKN2B—melanoma	0.000117	0.000336	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CD86—melanoma	0.000116	0.000333	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—CXCL8—melanoma	0.000116	0.000332	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ERBB4—melanoma	0.000116	0.000332	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PIK3CB—melanoma	0.000115	0.000331	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EDN1—melanoma	0.000115	0.00033	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CDKN2B—melanoma	0.000115	0.000329	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CD86—melanoma	0.000113	0.000325	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—CXCL8—melanoma	0.000113	0.000325	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EDN1—melanoma	0.000113	0.000323	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CSF2—melanoma	0.000112	0.000323	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FGF1—melanoma	0.000112	0.000323	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CD86—melanoma	0.000111	0.000318	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—CXCL8—melanoma	0.000111	0.000318	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—IL2—melanoma	0.000111	0.000318	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EDN1—melanoma	0.00011	0.000316	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—E2F1—melanoma	0.00011	0.000316	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CSF2—melanoma	0.00011	0.000316	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FGF1—melanoma	0.00011	0.000316	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3CB—melanoma	0.00011	0.000314	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PDGFRA—melanoma	0.000109	0.000312	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—IL2—melanoma	0.000108	0.000311	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ITGB3—melanoma	0.000108	0.000309	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PRKCA—melanoma	0.000108	0.000309	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—E2F1—melanoma	0.000108	0.000309	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FGF1—melanoma	0.000108	0.000309	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CSF2—melanoma	0.000108	0.000309	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3CB—melanoma	0.000107	0.000307	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PDGFRA—melanoma	0.000107	0.000306	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—IL2—melanoma	0.000106	0.000304	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SPP1—melanoma	0.000106	0.000303	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ITGB3—melanoma	0.000105	0.000303	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PRKCA—melanoma	0.000105	0.000303	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MAP2K2—melanoma	0.000105	0.000302	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CXCL8—melanoma	0.000105	0.000302	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—E2F1—melanoma	0.000105	0.000302	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3CB—melanoma	0.000105	0.000301	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PDGFRA—melanoma	0.000104	0.000299	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SPP1—melanoma	0.000103	0.000297	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ITGB3—melanoma	0.000103	0.000296	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PRKCA—melanoma	0.000103	0.000296	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MAP2K2—melanoma	0.000103	0.000296	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CXCL8—melanoma	0.000103	0.000295	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SPP1—melanoma	0.000101	0.00029	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MAP2K2—melanoma	0.000101	0.000289	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CXCL8—melanoma	0.000101	0.000289	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—IL2—melanoma	0.000101	0.000289	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TERT—melanoma	0.0001	0.000288	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RAC1—melanoma	9.99e-05	0.000287	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP17A1—melanoma	9.9e-05	0.000284	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—IL2—melanoma	9.84e-05	0.000282	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TERT—melanoma	9.8e-05	0.000281	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RAC1—melanoma	9.78e-05	0.00028	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—IL2—melanoma	9.62e-05	0.000276	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TERT—melanoma	9.59e-05	0.000275	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HIF1A—melanoma	9.58e-05	0.000275	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RAC1—melanoma	9.56e-05	0.000274	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HIF1A—melanoma	9.38e-05	0.000269	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GNA11—melanoma	9.35e-05	0.000268	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HIF1A—melanoma	9.17e-05	0.000263	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—KDR—melanoma	9.17e-05	0.000263	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—FASN—melanoma	9.15e-05	0.000262	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SLC5A5—melanoma	9e-05	0.000258	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—KDR—melanoma	8.97e-05	0.000257	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FN1—melanoma	8.82e-05	0.000253	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—KDR—melanoma	8.77e-05	0.000252	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GNAQ—melanoma	8.69e-05	0.000249	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CD44—melanoma	8.69e-05	0.000249	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NOTCH1—melanoma	8.63e-05	0.000248	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FN1—melanoma	8.63e-05	0.000248	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CD80—melanoma	8.46e-05	0.000243	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NOTCH1—melanoma	8.45e-05	0.000242	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—KIT—melanoma	8.44e-05	0.000242	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APC—melanoma	8.44e-05	0.000242	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CG—melanoma	8.44e-05	0.000242	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—NRAS—melanoma	8.44e-05	0.000242	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FN1—melanoma	8.44e-05	0.000242	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EGF—melanoma	8.35e-05	0.000239	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP1B1—melanoma	8.33e-05	0.000239	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CD80—melanoma	8.28e-05	0.000237	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—KIT—melanoma	8.26e-05	0.000237	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APC—melanoma	8.26e-05	0.000237	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CG—melanoma	8.26e-05	0.000237	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—NRAS—melanoma	8.26e-05	0.000237	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NOTCH1—melanoma	8.26e-05	0.000237	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EGF—melanoma	8.16e-05	0.000234	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CD80—melanoma	8.09e-05	0.000232	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—MAPK3—melanoma	8.09e-05	0.000232	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—KIT—melanoma	8.08e-05	0.000232	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APC—melanoma	8.08e-05	0.000232	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CG—melanoma	8.08e-05	0.000232	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—NRAS—melanoma	8.08e-05	0.000232	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EGF—melanoma	7.98e-05	0.000229	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—BRAF—melanoma	7.94e-05	0.000228	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—MAPK3—melanoma	7.91e-05	0.000227	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—BRAF—melanoma	7.76e-05	0.000223	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—MAPK3—melanoma	7.74e-05	0.000222	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IGF1—melanoma	7.73e-05	0.000222	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—MAPK1—melanoma	7.69e-05	0.000221	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—EGFR—melanoma	7.69e-05	0.000221	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—BRAF—melanoma	7.59e-05	0.000218	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IGF1—melanoma	7.56e-05	0.000217	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—MAPK1—melanoma	7.53e-05	0.000216	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—EGFR—melanoma	7.53e-05	0.000216	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MAP2K1—melanoma	7.47e-05	0.000214	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CD—melanoma	7.42e-05	0.000213	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IGF1—melanoma	7.4e-05	0.000212	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—MAPK1—melanoma	7.36e-05	0.000211	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—EGFR—melanoma	7.36e-05	0.000211	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	7.35e-05	0.000211	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MAP2K1—melanoma	7.31e-05	0.00021	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—KRAS—melanoma	7.27e-05	0.000208	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CD—melanoma	7.26e-05	0.000208	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	7.19e-05	0.000206	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MAP2K1—melanoma	7.15e-05	0.000205	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—KRAS—melanoma	7.11e-05	0.000204	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FGF2—melanoma	7.11e-05	0.000204	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CD—melanoma	7.1e-05	0.000204	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PIK3CA—melanoma	7.03e-05	0.000202	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FGF2—melanoma	6.95e-05	0.000199	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—KRAS—melanoma	6.95e-05	0.000199	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ABCB1—melanoma	6.86e-05	0.000197	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FGF2—melanoma	6.8e-05	0.000195	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3CA—melanoma	6.68e-05	0.000192	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MDM2—melanoma	6.65e-05	0.000191	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ERBB2—melanoma	6.56e-05	0.000188	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3CA—melanoma	6.53e-05	0.000187	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MDM2—melanoma	6.51e-05	0.000187	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CB—melanoma	6.47e-05	0.000186	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ERBB2—melanoma	6.41e-05	0.000184	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3CA—melanoma	6.39e-05	0.000183	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MDM2—melanoma	6.36e-05	0.000182	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CB—melanoma	6.33e-05	0.000182	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PRKCA—melanoma	6.32e-05	0.000181	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ERBB2—melanoma	6.27e-05	0.00018	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ERCC2—melanoma	6.26e-05	0.00018	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CXCL8—melanoma	6.22e-05	0.000178	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CB—melanoma	6.19e-05	0.000178	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—HRAS—melanoma	6.18e-05	0.000177	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CXCL8—melanoma	6.08e-05	0.000174	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CDKN1B—melanoma	6.07e-05	0.000174	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—HRAS—melanoma	6.04e-05	0.000173	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—AKT1—melanoma	6.01e-05	0.000172	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CASP3—melanoma	5.95e-05	0.000171	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CXCL8—melanoma	5.95e-05	0.000171	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL2—melanoma	5.94e-05	0.00017	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CDKN1B—melanoma	5.94e-05	0.00017	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—IL6—melanoma	5.91e-05	0.00017	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—HRAS—melanoma	5.91e-05	0.00017	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—AKT1—melanoma	5.88e-05	0.000169	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CASP3—melanoma	5.82e-05	0.000167	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL2—melanoma	5.81e-05	0.000167	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CDKN1B—melanoma	5.81e-05	0.000167	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCND1—melanoma	5.79e-05	0.000166	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—IL6—melanoma	5.78e-05	0.000166	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—AKT1—melanoma	5.75e-05	0.000165	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CTNNB1—melanoma	5.74e-05	0.000165	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CASP3—melanoma	5.69e-05	0.000163	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL2—melanoma	5.68e-05	0.000163	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCND1—melanoma	5.67e-05	0.000163	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—IL6—melanoma	5.66e-05	0.000162	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MMP9—melanoma	5.62e-05	0.000161	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CTNNB1—melanoma	5.61e-05	0.000161	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CDKN1A—melanoma	5.6e-05	0.000161	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PTEN—melanoma	5.59e-05	0.00016	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NFKB1—melanoma	5.56e-05	0.00016	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCND1—melanoma	5.54e-05	0.000159	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MMP9—melanoma	5.5e-05	0.000158	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CTNNB1—melanoma	5.49e-05	0.000157	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CDKN1A—melanoma	5.48e-05	0.000157	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PTEN—melanoma	5.47e-05	0.000157	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AKT1—melanoma	5.45e-05	0.000156	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NFKB1—melanoma	5.44e-05	0.000156	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MMP9—melanoma	5.38e-05	0.000154	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CDKN1A—melanoma	5.36e-05	0.000154	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PTEN—melanoma	5.35e-05	0.000153	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AKT1—melanoma	5.34e-05	0.000153	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NFKB1—melanoma	5.32e-05	0.000153	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AKT1—melanoma	5.22e-05	0.00015	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—VEGFA—melanoma	5.05e-05	0.000145	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—STAT3—melanoma	5e-05	0.000143	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NRAS—melanoma	4.99e-05	0.000143	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CG—melanoma	4.95e-05	0.000142	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—VEGFA—melanoma	4.94e-05	0.000142	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—STAT3—melanoma	4.89e-05	0.00014	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NRAS—melanoma	4.88e-05	0.00014	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—VEGFA—melanoma	4.83e-05	0.000139	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—STAT3—melanoma	4.78e-05	0.000137	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MAPK3—melanoma	4.78e-05	0.000137	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPARG—melanoma	4.77e-05	0.000137	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NRAS—melanoma	4.77e-05	0.000137	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MAPK3—melanoma	4.67e-05	0.000134	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MYC—melanoma	4.65e-05	0.000133	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MAPK3—melanoma	4.57e-05	0.000131	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MAPK1—melanoma	4.55e-05	0.00013	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MYC—melanoma	4.55e-05	0.00013	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EGFR—melanoma	4.54e-05	0.00013	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MAPK1—melanoma	4.45e-05	0.000128	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EGFR—melanoma	4.45e-05	0.000128	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MYC—melanoma	4.44e-05	0.000127	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CD—melanoma	4.35e-05	0.000125	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MAPK1—melanoma	4.35e-05	0.000125	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EGFR—melanoma	4.35e-05	0.000125	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—KRAS—melanoma	4.29e-05	0.000123	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALB—melanoma	4.29e-05	0.000123	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—KRAS—melanoma	4.2e-05	0.00012	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—KRAS—melanoma	4.11e-05	0.000118	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CA—melanoma	3.94e-05	0.000113	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CA—melanoma	3.86e-05	0.000111	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TP53—melanoma	3.82e-05	0.000109	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CB—melanoma	3.79e-05	0.000109	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CA—melanoma	3.77e-05	0.000108	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PTGS2—melanoma	3.76e-05	0.000108	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TP53—melanoma	3.73e-05	0.000107	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TP53—melanoma	3.65e-05	0.000105	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HRAS—melanoma	3.65e-05	0.000105	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HRAS—melanoma	3.57e-05	0.000102	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL6—melanoma	3.49e-05	0.0001	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HRAS—melanoma	3.49e-05	0.0001	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL6—melanoma	3.42e-05	9.8e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL6—melanoma	3.34e-05	9.58e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PTEN—melanoma	3.28e-05	9.4e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AKT1—melanoma	3.22e-05	9.24e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AKT1—melanoma	3.15e-05	9.04e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AKT1—melanoma	3.08e-05	8.84e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CA—melanoma	2.31e-05	6.63e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AKT1—melanoma	1.89e-05	5.42e-05	CbGpPWpGaD
